Select Page
Myra Vision Logo

Sight for Life

Personalized Flow. IOP Control.

Designed to be the first-of-its-kind  treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma. 

Icon of an eye

Aims to Deliver IOP Control
Personalized flow for evolving patient needs

Icon of an Safety Check

Safety Without Sacrificing Efficacy
Intends to address gaps in treatments for patients with moderate to severe glaucoma

Icon of MIGS

Established Delivery Technique
Approach provides predictable outcomes

Latest News

Jun. 1, 2021

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings
Company to accelerate development of the first-of-its-kind treatment for patients with moderate to severe glaucoma

Oct. 10, 2019

Myra Medical, A Shifamed Portfolio Company, Closes $3M In Seed Financing
Company is innovating next-generation treatment for moderate to advanced glaucoma